All Companies

SYKCongressional Stock Trades

Stryker Corporation

Surgical & Medical Instruments & Apparatus

Congressional stock trades in Stryker Corporation (SYK) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.

Total Trades

22

Politicians Trading

7

Last Traded

Jul 22, 2026

Trading History

PoliticianNotifiedTradedTypeAmountChange
Thomas H. Kean, Jr.RAug 18, 2026Jul 22, 2026Sell$1,001 - $15,000-11.03%
Thomas H. Kean, Jr.RJul 15, 2026Jun 2, 2026Sell$1,001 - $15,000-6.20%
Thomas H. Kean, Jr.RFeb 19, 2026Jan 23, 2026Sell$15,001 - $50,000-22.51%
Julia LetlowRJan 13, 2026Oct 16, 2025Sell$1,001 - $15,000-25.49%
Gilbert Ray Cisneros, Jr.DJan 12, 2026Dec 10, 2025Buy$1,001 - $15,000-22.24%
Thomas H. Kean, Jr.RDec 19, 2025Nov 20, 2025Sell$15,001 - $50,000-23.68%
Gilbert Ray Cisneros, Jr.DDec 15, 2025Nov 18, 2025Buy$1,001 - $15,000-23.48%
Gilbert Ray Cisneros, Jr.DNov 18, 2025Oct 17, 2025Buy$1,001 - $15,000-26.52%
Thomas H. Kean, Jr.ROct 14, 2025Sep 12, 2025Sell$15,001 - $50,000-28.23%
Thomas H. Kean, Jr.RSep 18, 2025Aug 25, 2025Sell$1,001 - $15,000-29.62%
Thomas H. Kean, Jr.RAug 20, 2025Jul 31, 2025Sell$15,001 - $50,000-29.95%
Thomas H. Kean, Jr.RJul 16, 2025Jun 26, 2025Sell$15,001 - $50,000-29.53%
Jefferson ShreveRJun 22, 2025May 12, 2025Sell$50,001 - $100,000-29.11%
Julie JohnsonDMay 14, 2025Apr 7, 2025Sell$1,001 - $15,000-20.33%
Jared MoskowitzDMay 9, 2025Apr 7, 2025Buy$1,001 - $15,000-20.33%
Jefferson ShreveRMay 8, 2025Apr 17, 2025Buy$15,001 - $50,000-20.60%
Robert BresnahanRMay 8, 2025Apr 8, 2025Sell$1,001 - $15,000-18.45%
Robert BresnahanRMay 8, 2025Apr 8, 2025Sell$1,001 - $15,000-18.45%
Jefferson ShreveRApr 11, 2025Mar 13, 2025Sell$50,001 - $100,000-24.35%
Thomas H. Kean, Jr.RMar 14, 2025Feb 26, 2025Sell$15,001 - $50,000-29.77%
Jared MoskowitzDFeb 10, 2025Jan 15, 2025Buy$1,001 - $15,000-25.36%
Jared MoskowitzDFeb 10, 2025Jan 15, 2025Buy$1,001 - $15,000-25.36%

Price History

About Stryker Corporation

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.